Announcements

29 September 2026
Tu Youyou Award—Final Call for Nominations


The nomination deadline for the Tu Youyou Award is approaching. Researchers are encouraged to submit nominations by 31 October 2026 (UTC-12).

The Tu Youyou Award recognizes outstanding researchers whose work has made significant contributions to natural products chemistry and medicinal chemistry, advancing scientific innovation and human health. It is named after Nobel laureate Tu Youyou, whose discovery of artemisinin has saved millions of lives. 

The current award committee is chaired by Prof. Dr. William Gerwick, a Distinguished Professor at the University of California San Diego, USA, and a renowned expert in marine natural products chemistry and pharmacology. Under his leadership, the committee will evaluate nominations and recognize impactful research achievements in the related fields. 

Prize:

  • CHF 100,000
  • A medal
  • A certificate

The monetary prize will be shared equally should there be multiple recipients.

Who may be nominated?

  • Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.

Nominees must be individuals; team or group nominations are not permitted. Nominations are valid only for the current award cycle. 

Who may submit a nomination?

  • The director of the nominee’s host research institution or a recognized scientist within the field.

Self-nominations will not be considered. 

Nomination materials:

  • A biographical sketch
  • A detailed description of the nominee’s contributions
  • 5–10 representative academic publications
  • A list of academic honors, awards, and funded projects
  • A nomination letter signed by two nominators 

How to submit?
Submit your nomination by 31 October 2026 via: https://tuyouyouprize.org/nomination/form. 

For further information, please visit the Tu Youyou Award website. For any inquiries, please contact the Tu Youyou Award Team at tuyouyouaward@mdpi.com.

30 September 2026
2026 Nobel Prize—Where Breakthroughs Meet Open Sciences


Each October, the Nobel Prizes turn the world’s attention toward the discoveries that have redrawn the boundaries of science. They are science’s most prestigious recognition, and increasingly its most interdisciplinary. Recent laureates have been honored for work spanning quantum dots, machine learning, and molecular medicine, fields that rarely stay within a single discipline’s borders for long.

Open access has a growing role in that story. To date, more than 40 Nobel laureates have published their research in MDPI journals—a body of work spanning genetics, physics, chemistry, and medicine. Publishing openly means a laureate’s findings reach not only fellow scientists, but the students, clinicians, policymakers, and curious readers who would otherwise meet that work only secondhand, if at all. Open access doesn’t just carry Nobel-level research, it amplifies the voice behind it, letting the discovery speak directly to everyone it stands to affect.

This is also where MDPI’s breadth becomes an advantage. With over 500 journals covering the full spectrum of scientific inquiry, our platform mirrors the reality of modern discovery—where breakthroughs increasingly emerge at the intersection of fields, not within the walls of one. It’s this structure that lets us support interdisciplinary work from first submission to global publication, connecting researchers across borders and disciplines alike.

As this year’s laureates are announced, we’ll continue spotlighting where Nobel Prize–winning research intersects with the work of our authors, editors, and reviewers—celebrating both the achievements being recognized and the open access model that helps ensure they reach the widest possible audience.

Explore selected works by Nobel laureates within the MDPI portfolio below, and join us in celebrating the global impact of their ideas.

Put your scientific intuition to the test and join MDPI’s 2026 Nobel Prize Prediction Challenge! As we honor three decades of open research, we invite you to cast your votes for the next trailblazing laureates in chemistry, physics, and physiology or medicine. Predict the pioneer minds shaping tomorrow’s scientific legacy for a chance to win 100 CHF voucher of MDPI Video Service.

Deadline: 4 October 2026 | 18:00 CEST
Winner announcement: 16 October 2026

Discover high-impact research driving tomorrow’s breakthroughs. Browse our open access selections in Chemistry & Materials Science, Medicine & Pharmacology, and Physical Sciences, featuring key studies aligned with this year’s top Nobel prize-contending topics.

Chemistry & Materials Science

Medicine & Pharmacology

Physical Sciences

Join our distinguished Editors-in-Chief and Section Editors-in-Chief for an exclusive live discussion on this year’s Nobel Prize announcements. Our expert panel will break down the winning breakthroughs, explore their global impact, and discuss the future trajectories of open science across Chemistry, Physics, and Medicine. Don’t miss this opportunity to engage with leading voices in research.

2026 Nobel Medicine & Pharmacology Roundtable
5 October 2026, 13:00 (CEST)
Speakers: Prof. Dr. Patricia Schofield, Prof. Dr. Süleyman Ergün, Prof. Dr. Jens Coorssen and Dr. Andre van Zundert

2026 Nobel Physics Roundtable
6 October 2026, 15:00 (CEST)
Speakers: Prof. Dr. Andrey Starikovskiy, Dr. Gerald B. Cleaver and Dr. Amir-Abbas Haghighirad

2026 Nobel Chemistry & Materials Roundtable
7 October 2026, 13:00 (CEST)
Speakers: Prof. Dr. Eugenia Valsami-Jones, Prof. Dr. Sotirios Baskoutas, Dr. Luca Vattuone, Prof. Dr. Esmaiel Jabbari and Prof. Dr. Shin-ichi Yusa

2026 Nobel Chemistry & Materials Roundtable Session #2
7 October 2026, 13:00 (CEST)
Speakers: Prof. Dr. Manoj Gupta, Prof. Dr. Pankaj Vadgama, Prof. Dr. Oliver Kröcher and Prof. Dr. Vasileios Koutsos

MDPI remains committed to ensuring that the breakthroughs of today—and tomorrow—are shared, debated, and built upon by the global research community. Explore science, join the conversation, and be part of the next chapter.

30 September 2026
MDPI INSIGHTS: The CEO’s Letter #39 - Peer Review Week, Chief Publishing Officer, Tu Youyou Award, OASPA & AI

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Recognizing the People Behind Peer Review

September marked Peer Review Week 2026, this year focused on “Peer Review Capacity: Volume, Speed, and Quality.” The theme reflects a challenge across scholarly publishing: research output and submissions continue to grow, while the time and expertise researchers can dedicate to reviewing are finite.

At MDPI, more than 200,000 reviewers contribute their expertise each year. Their work is fundamental to maintaining the quality and integrity of the research we publish, and Peer Review Week gave us an opportunity not only to thank them, but also to reflect on how we can better support their contribution.

This year, we highlighted three commitments that guide our approach: protecting reviewers’ time and judgment, ensuring high-quality and efficient processes, and recognizing and rewarding reviewers for their contribution. We also shared results from our 2026 Voice of the Community surveys. Among 1,627 reviewer respondents, 86% rated their experience with MDPI as “Good” or “Excellent,” 88% said manuscripts matched their expertise, and 92% found our reviewer instructions clear and helpful. From the author perspective, 95% of 16,795 respondents agreed that reviewers’ comments helped improve their manuscripts.

Recognition is an important part of this relationship too. Through our Top 1000 Reviewers program, 743 scholars accepted awards this year, with a combined CHF 526,500 returned directly to the reviewer community through cash awards and APC vouchers. During Peer Review Week, we also created opportunities for reviewers to share their own experiences through webinars, including The Reviewer’s Perspective: Navigating Volume, Speed, and Quality in Peer Review and our UK Reviewer Club.

Peer review ultimately depends on people choosing to give their time and expertise to the work of other researchers. As publishing continues to evolve, including through new technologies and increasing research volumes, we should not lose sight of that human contribution. Thank you to all the reviewers who work with MDPI, and to our colleagues who support them every day.

Read more about Peer Review Week 2026 here.

Inside MDPI

Welcoming Dr. Constanze Schelhorn as MDPI’s Chief Publishing Officer

This month, we announced the appointment of Dr. Constanze Schelhorn as MDPI’s Chief Publishing Officer (CPO). The appointment marks an important step for MDPI and the latest chapter in a journey within the organization that now spans a decade.


Stefan Tochev (CEO, MDPI) with Constanze at STM, Frankfurt, Germany, October 2025.

Constanze joined MDPI in June 2016 and has taken on several different responsibilities across editorial, indexing, and publishing over the years.

Since 2023, she has held leadership roles as Head of Indexing and later Head of Publishing, before taking on the role of Chief Publishing Officer.

I’ve had the opportunity to work with Constanze over many of those years and to see her take on increasingly important responsibilities.

What I’ve always appreciated is the growth mindset and expertise she brings to her work, together with a commitment to quality.

She understands how MDPI works and how the publishing environment is evolving to meet the expectations of the academic communities we serve.

Looking Ahead

Publishing has changed considerably over the past decade, and that change is only accelerating. Research integrity, artificial intelligence, editorial standards, indexing requirements, new publishing models, and changing expectations from researchers and institutions are just some of the areas we are navigating.


Stefan Tochev (CEO, MDPI) with Constanze and Prof. Dr. Manoj Gupta, Editor-in-Chief of MDPI journal Technologies, in Singapore, January 2025.

MDPI has changed considerably too. As we celebrate our 30th anniversary this year, our journal portfolio now includes more than 540 titles, and the scale of our work brings greater opportunities and responsibilities.

Continuing to develop our publishing practices and ensuring that we respond to changes in academic publishing will remain important priorities for us.

Constanze’s experience across several areas of MDPI puts her in a position to help us do that.

As CPO, she will help provide strategic direction across our publishing functions while working with colleagues throughout the organization. She will also represent MDPI with external stakeholders, including industry organizations and indexing partners, ensuring that we remain engaged in the conversations shaping the future of publishing.

“Please join me in congratulating Constanze on her appointment”

Growing Together

There is another aspect of this appointment that I think is worth recognizing about MDPI. I appreciate seeing people develop alongside the organization. Constanze’s journey from joining MDPI in 2016 to becoming our Chief Publishing Officer ten years later is a good example of what can happen when experience, knowledge, and responsibility build over time.

Our 30th anniversary naturally gives us an opportunity to look back at how far MDPI has come. But it should also make us think about the people who will shape where we go next. I’m pleased that Constanze will be one of those people.

Please join me in congratulating Constanze on her appointment as we look forward to continuing to work with her in this new role and seeing what we can accomplish together.

P.S. A fun fact about Constanze: she loves climbing. So, if she’s visiting your city and you’re wondering how to make her feel at home, point her towards the nearest climbing gym.

Here’s a photo from a climbing session during our visit to the Singapore office in January 2025. 

Impactful Research

A Decade of the Tu Youyou Award: Celebrating Scientific Excellence

Few examples demonstrate the potential impact of scientific research as clearly as Professor Tu Youyou's discovery of artemisinin. Her team’s work contributed to the development of artemisinin-based combination therapies for malaria, which the World Health Organization (WHO) recommends as the main treatment for P. falciparum malaria.

Behind that achievement is also a remarkable scientific journey: drawing on knowledge from traditional Chinese medicine, Professor Tu and her team investigated hundreds of extracts before identifying artemisinin and helping transform the treatment of malaria.

This legacy is at the heart of the Tu Youyou Award, established by MDPI in 2016 to recognize outstanding achievements in natural products chemistry and medicinal chemistry.

“Professor Tu Youyou's scientific journey is an extraordinary example”

Ten Years of the Tu Youyou Award

This year marks a decade since the award was established. Over that time, six scholars have been recognized as Tu Youyou laureates for their contributions to research and innovation.

The connection between MDPI and Professor Tu Youyou’s work goes back even further. In 2009, MDPI Founder and President, Dr. Shu-Kun Lin, launched a Special Issue in MDPI journal Molecules commemorating Professor Tu’s 80th birthday, several years before the establishment of the award.

Below is a photo of Professor Tu Youyou with MDPI Founder and President Dr. Shu-Kun Lin during an MDPI visit to congratulate Professor Tu on receiving the 2015 Nobel Prize in Physiology or Medicine.

The 2026 Tu Youyou Award continues this tradition, awarding CHF 100,000, together with a medal and certificate, to recognize the achievements in natural products chemistry and medicinal chemistry.

Scientific Excellence and Impact

Professor Dr. William Gerwick, Chair of the 2026 Tu Youyou Award Committee, recently reflected on what distinguishes the award: “This award is truly special in that it recognizes scientific excellence as well as impact.”

I think this combination is important. Research advances our understanding, but its influence can extend much further: inspiring new discoveries, informing new treatments, addressing societal challenges, and ultimately improving people’s lives.

Professor Tu Youyou's scientific journey is an extraordinary example. Her work combined rigorous scientific investigation with a problem of enormous human importance, ultimately contributing to treatments that have transformed the fight against malaria.

Recognizing researchers who continue this tradition allows us to celebrate both scientific achievement and the broader contribution research can make to society.

Nominations Open Until 31 October

Nominations for the 2026 Tu Youyou Award are now open to scientists with outstanding achievements and contributions in natural products chemistry and medicinal chemistry. Nominations may be submitted by directors of nominees’ host research institutions or scientists within the field. Self-nominations are not accepted.

The nomination deadline is 31 October 2026, with the announcement of the winner planned for March 2027.

Learn More

Coming Together for Science 

OASPA 2026: Conversations Shaping the Future of Open Access

From 21–23 September, I attended the 2026 Conference of the Open Access Scholarly Publishing Association (OASPA) in Zagreb, Croatia.

 MDPI has been a Platinum Sponsor of the OASPA conference for several years, supporting an event that brings together the open access (OA) community to discuss some of the opportunities and challenges shaping publishing. This year, MDPI also sponsored the conference reception at the City Museum of Zagreb.

The program covered topics from sustainable publishing and research assessment to open infrastructure, new models for OA agreements, and, of course, the growing influence of artificial intelligence (AI). For me, though, the value of conferences like OASPA goes beyond the program. It’s about hearing different perspectives from across publishing, reconnecting with familiar faces, building new relationships, and having conversations that sometimes lead somewhere unexpected.


Stefan Tochev (CEO, MDPI) at the OASPA conference in Zagreb, Croatia.

Open Access in the Age of AI

One discussion I particularly enjoyed was the opening-day panel, “Does open access still matter in a Gen AI world?” As AI continues to become an interface through which people discover and interact with research, making knowledge openly available remains important. But questions around trust, provenance, governance, and responsibility are becoming more difficult to separate from the OA conversation.

Who is responsible for ensuring that AI-generated or AI-mediated information can be trusted? What responsibilities sit with publishers, researchers, institutions, infrastructure providers, and AI companies? And, perhaps most importantly, how do we work together rather than trying to address these challenges in isolation?

There are no simple answers, but hearing these discussions highlighted the fact that many of us across publishing are working with similar questions. Creating spaces where we can explore them together is valuable.

“Who is responsible for ensuring that AI-generated or AI-mediated information can be trusted?”

Conversations That Lead Somewhere

The conference also reminded me of the value of simply meeting people. I had a great conversation with César Pallares from Consortia Colombia about the publishing ecosystem in Colombia and the possibility of exploring a consortium agreement with MDPI in Colombia. César was very open to continuing the conversation, and I’ve already connected this opportunity with colleagues from our Institutional Open Access Program (IOAP) team.

I also caught up with Yvonne Campfens, Executive Director of OA Switchboard, who has recently taken on the role of Director for the Academic Publishing in Europe (APE) conference. We look forward to continuing to support APE as part of MDPI’s broader commitment to academic and publishing-industry events.

And, of course, it was good to connect with familiar faces from previous OASPA conferences and meet new ones. These conversations happen over coffee, between sessions, at receptions, or sometimes while walking through a city. Not every conversation needs to result in a project or partnership. Sometimes the value is simply understanding another perspective, sharing what we’re working on, or beginning a relationship that develops over time.

Thank you to the OASPA team, speakers, moderators, participants, and fellow sponsors for creating that space in Zagreb. I’m pleased that MDPI could once again support the conference and, more importantly, be part of the conversations taking place there. I look forward to seeing where some of them lead.

Closing Thoughts

AI Is Making Science More Accessible. How Do We Keep It Trustworthy?

Artificial Intelligence (AI) is changing how people find, understand, and interact with scientific research.

For decades, one of the biggest barriers to engaging with scientific research was access. Open Access (OA) has helped change that, with around 61% of global journal articles, reviews, and conference papers published in 2025 now openly accessible. AI is now beginning to lower another barrier: understanding. Researchers can quickly navigate large volumes of literature, patients can ask for complex medical research to be explained in plain language, and policymakers can more easily explore findings outside their own areas of expertise.

But easier access and understanding don’t automatically make scientific information easier to trust.

This is the topic explored by our Scientific Communications Lead, Dr. Giulia Stefenelli, in her recent article for Research Information, Scientific literacy must keep pace with artificial intelligence.

A recent study cited in the article found that when GPT-4o was tested without external retrieval and asked to cite recent scientific literature, it fabricated citations in 78–90% of cases. By contrast, OpenScholar, a specialized AI system that retrieves information from millions of OA papers, achieved citation accuracy comparable to human experts.

One line about the gap between AI content generation and verification particularly stood out to me: “Generation is becoming cheap, but verification is not.” While AI can reproduce the appearance of credible scientific information, verifying the underlying data, references, methods, and conclusions still requires time, expertise, and access to the evidence.

“The important question is whether the underlying research can be trusted”

Detection Is Not Verification

Giulia’s distinction between AI detection and research verification is particularly relevant to scholarly publishing. A manuscript can contain AI-assisted language and report sound research. Equally, something written entirely by a person can contain fabricated data, inappropriate methods, or unsupported conclusions. The important question isn’t only “Was AI used?” but whether the underlying research can be trusted.

For publishers, this makes strong editorial processes, expert peer review, research integrity checks, transparency, and human accountability increasingly important.

A Shared Responsibility

Giulia argues that publishers cannot address this challenge alone. Researchers, institutions, publishers, technology providers, and readers all have a role to play in how scientific information is created, evaluated, communicated, and understood.

As AI continues to develop, our understanding of scientific literacy must develop alongside it. Making knowledge accessible and helping people understand it are important. The next question is: how do we make it easier for people to examine where information comes from and decide how much confidence it deserves?

You can read the full article on Research Information. It is a great example of the expertise within MDPI contributing to conversations about the future of scientific publishing and communications. Technology can help us address some of these challenges, but ultimately people must remain accountable for the decisions that shape the scientific record.

Stefan Tochev
Chief Executive Officer
MDPI AG

29 September 2026
Nobel Prize in Physiology or Medicine—Where Breakthroughs Meet Open Sciences


Since 1901, the Nobel Prizes have celebrated the moments when human curiosity breaks new ground — achievements that so often start small: an unexpected result, a question nobody else thought to ask, an idea pursued long before its value was clear. More than a tribute to individual achievement, the Nobel Prize honors the patience and imagination that quietly rewrite what we know, and expand what's possible for generations to come.

Join us for an upcoming webinar as our experts revisit the groundbreaking research of past laureates in physiology or medicine and examine the trends currently shaping the field. This session will offer a deeper understanding of how past breakthroughs continue to influence the direction of modern research.

Keynote Speakers:

Dr. Andre van Zundert
Section Editor-in-Chief of Healthcare
The University of Queensland, Australia
Prof. Dr. Süleyman Ergün
Editor-in-Chief of Organoids
University of Würzburg, Würzburg, Germany
Prof. Dr. Jens Coorssen
Editor-in-Chief of Proteomes
Institute for Globally Distributed Open Research and Education (IGDORE), Canada
Prof. Dr. Patricia Schofield
Section Editor-in-Chief of Geriatrics
University of Plymouth, UK

“Research Progress on Downstream Mechanisms of Glucose Metabolic Reprogramming and Its Role in the Occurrence and Progression of Type 2 Diabetes Mellitus”
by Chan Wu, Maoying Wei, Aijing Li, Qingyi Zhu, Jingyi Guo, Anning Sun, Xin Gu, Yincheng Li and Yanbing Gong
Biomedicines 2026, 14(7), 1427; https://doi.org/10.3390/biomedicines14071427

“Metformin as an Innate Immune Modulator: Metabolic and Epigenetic Reprogramming of Innate Immune Cells and Therapeutic Implications”
by Yunfeng Shi and Sheng Xia
Curr. Issues Mol. Biol. 2026, 48(6), 642; https://doi.org/10.3390/cimb48060642

“Glucagon‑like Peptide‑1 Receptor Agonists in Rheumatoid Arthritis: A Scoping Review of Metabolic, Anti‑Inflammatory, and Cardioprotective Effects”
by Simona Buonanno, Carla Gaggiano, Caterina Baldi, Luca Cantarini, Bruno Frediani and Stefano Gentileschi
J. Pers. Med. 2026, 16(6), 284; https://doi.org/10.3390/jpm16060284

“Metabolism and Metabolic Reprogramming in Laryngeal Squamous Cell Carcinoma”
by Barbara Verro, Roberta Oliveri, Giovanni Pratelli, Marianna Lauricella, Diana Di Liberto, Anna De Blasio, Daniela Carlisi and Carmelo Saraniti
Biomedicines 2026, 14(5), 959; https://doi.org/10.3390/biomedicines14050959

“Microbiota–Gut–Brain Axis Disruption, Neuroinflammation, and Potential Antioxidant‑Based Treatments in Metabolic Diseases”
by Jazmín Carro‑Rodríguez, Gabriela Ibáñez‑Cervantes, Noemí Cárdenas‑Rodríguez, Iván Ignacio‑Mejía, Exsal Manuel Albores‑Méndez, Blanca Rosalba Pardo‑Pacheco, Verónica Fernández‑Sánchez, Ana María Balboa‑Verduzco, Cecilia Adame, Eleazar Lara‑Padilla et al.
Antioxidants 2026, 15(4), 522; https://doi.org/10.3390/antiox15040522

“Integrating Untargeted Metabolomics and Transcriptomics in Mice with Pulmonary Tuberculosis to Reveal Changes in Linoleic Acid and Its Metabolism in Lung Monocyte‑Derived Macrophages”
by Yuxia Sha, Xiaoman Zhao, Hongying Zhu, Ye Li, Meilin Shao, Shenggang Ding and Haoquan Zhou
Pathogens 2026, 15(3), 254; https://doi.org/10.3390/pathogens15030254

“Integrated Multi‑Omics Analysis Reveals Dysregulated Lipid Metabolism as a Novel Mechanism in Androgenetic Alopecia”
by Xiao‑Shuang Yang, Liyang Duan, Yu‑Jie Miao, Zhongfa Lu and Ru Dai
Biomedicines 2026, 14(1), 160; https://doi.org/10.3390/biomedicines14010160

“Insulin Resistance in Bipolar Disorder: A Real‑World Cross‑Sectional Study”
by Andrea Aguglia, Matteo Meinero, Valentina Aprile, Tommaso Cerisola, Giuditta Mazzarello, Angelo Oggianu, Alessandra Costanza, Mario Amore, Andrea Amerio and Gianluca Serafini
J. Pers. Med. 2026, 16(1), 47; https://doi.org/10.3390/jpm16010047

Special Issues:

“Bone Metabolism and Skeletal Health in Diabetes”
Guest Editor: Dr. Shivani Srivastava
Deadline for manuscript submissions: 20 January 2027
“New Insights into Lipid Metabolism in Health and Disease”
Guest Editor: Dr. Arleta Drozd
Deadline for manuscript submissions: 28 February 2027

“Modeling Context‑Dependent Tumor Metabolism in 3D Systems: Implications for Functional Precision Oncology”
by Maria Virginia Giolito, Olivier Feron and Cyril Corbet
Organoids 2026, 5(3), 22; https://doi.org/10.3390/organoids5030022

“Genetic Interruption of PD‑1/PD‑L1 as an Alternative Means for Immune Checkpoint Blockade in Cancer: A Review”
by Dan Li, Jiao Lu, Qianru Li, Huan Deng and Songwei Tan
Pharmaceutics 2026, 18(6), 752; https://doi.org/10.3390/pharmaceutics18060752

“Treatment‑Related Myelodysplastic Syndrome and Acute Myeloid Leukemia Associated with CAR T‑Cell Therapies: A Real‑World FAERS Pharmacovigilance Study”
by Connor Frey
Lymphatics 2026, 4(2), 21; https://doi.org/10.3390/lymphatics4020021

“Hidden Targets in Cancer Immunotherapy: The Potential of “Dark Matter” Neoantigens”
by Francois Xavier Rwandamuriye, Alec J. Redwood, Jenette Creaney and Bruce W. S. Robinson
Vaccines 2026, 14(1), 104; https://doi.org/10.3390/vaccines14010104

“Emerging Cell‑Based Therapies for Systemic Sclerosis: From Stem Cells to CAR‑T Cells”
by Vitaly Chasov, Sabir Mukhametshin, Elvina Gilyazova, Damir Davletshin, Mariya Tikhomirova, Iuliia Topchu, Aygul Valiullina, Marcella Prete and Emil Bulatov
Curr. Issues Mol. Biol. 2026, 48(1), 76; https://doi.org/10.3390/cimb48010076

“Microbial Modulation: Unraveling the Influence of Gut Microbiota on Macrophage Polarization in Tumor Microenvironments”
by Jonathan Trejo, Hayes Koegeboehn, Farah Faizuddin, Ryan Logan, Michel Toutoungy, Aadil Sheikh, Tamer E. Fandy, Sergio Saucedo, Victor M. Vasquez, Jr., Thien Nguyen et al.
Cells 2026, 15(2), 136; https://doi.org/10.3390/cells15020136

“Adipose Stromal Cell‑Derived Cancer‑Associated Fibroblasts Promote Pancreatic Adenocarcinoma Progression Through SFRP4 Signaling”
by Joseph Rupert, Lingyi Cai, Alexes C. Daquinag, Dimitris Anastassiou and Mikhail G. Kolonin
Cancers 2026, 18(2), 233; https://doi.org/10.3390/cancers18020233

“BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B‑Cell and Immune Disorders”
by Andrea Duminuco, Paola De Luca, Gaia Stanzione, Laura Anastasia Caruso, Giulio Lavenia, Salvatore Scarso, Bruno Garibaldi, Fanny Erika Palumbo, Calogero Vetro and Giuseppe Alberto Palumbo
Biomolecules 2026, 16(1), 123; https://doi.org/10.3390/biom16010123

Special Issues:

“Cancer Immunotherapy: Molecular Research and Application”
Guest Editors: Dr. Joaquin Marco-Brualla and Prof. Dr. Alberto Anel
Deadline for manuscript submissions: 15 December 2026
“Mechanisms and Innovations in Natural Killer Cell-Based Immunotherapy”
Guest Editor: Dr. Dipnarine Maharaj
Deadline for manuscript submissions: 28 February 2027

“Sulbactam–Durlobactam for Carbapenem-Resistant Acinetobacter baumannii–calcoaceticus Complex”
by Francesco Nappi
Pathogens 2026, 15(4), 449; https://doi.org/10.3390/pathogens15040449

“Reduced Left Ventricular Ejection Fraction as a Marker of Vulnerability to Healthcare-Associated Infections in Coronary Care Unit Patients: A Single-Centre Cohort Study”
by Daniela-Mirela Vîrtosu, Angela Dragomir, Simina Crișan, Silvia Luca, Oana Pătru, Ruxandra-Maria Băghină, Mihai-Andrei Lazăr, Alina-Ramona Cozlac, Stela Iurciuc and Constantin-Tudor Luca
J. Clin. Med. 2026, 15(5), 1789; https://doi.org/10.3390/jcm15051789

“Dissecting Cell Death Pathways in Influenza A virus Infection: Comparative Insights from Human Models”
by Ngoc Mai Khoi Nguyen, Alison C. West, Rebecca L. Ambrose and Michelle D. Tate
Viruses 2026, 18(2), 246; https://doi.org/10.3390/v18020246

“Effect of Hantavirus Infection on the Rodent Lung Microbiome: Specific Regulatory Roles of Host Species and Virus Types”
by Yaru Xiong, Zhihui Dai, Fangling He, Rongjiao Liu, Juan Wang, Zhifei Zhan, Huayun Jia, Shengbao Chen and Liang Cai
Microorganisms 2026, 14(1), 244; https://doi.org/10.3390/microorganisms14010244

“Vaccination Against Respiratory Infections in Adults with Cancer: A Concise Guide for Clinicians”
by Kay Choong See
Vaccines 2026, 14(1), 105; https://doi.org/10.3390/vaccines14010105

“Pathogen Evasion of Humoral Innate Immunity: Coping with C-Reactive Protein and Serum Amyloid A”
by Weichen Gong, Xuefei Cheng, Julio Villena and Haruki Kitazawa
Int. J. Mol. Sci. 2026, 27(2), 1072; https://doi.org/10.3390/ijms27021072

“Antioxidant and Anti-Inflammatory Activities of Probiotic Strains”
by Olga Adriana Caliman-Sturdza, Josiana A. Vaz, Ancuta Veronica Lupaescu, Andrei Lobiuc, Codruta Bran and Roxana Elena Gheorghita
Int. J. Mol. Sci. 2026, 27(2), 1079; https://doi.org/10.3390/ijms27021079

“Reinfection-Driven Accumulation of SARS-CoV-2 Antibodies: A 36-Month Longitudinal Study in Austrian Blood Donors”
by Orkan Kartal, Alexandra Domnica Hoeggerl, Wanda Lauth, Lisa Weidner, Natalie Badstuber, Christoph Grabmer, Christof Jungbauer, Verena Nunhofer, Heidrun Neureiter, Nina Held et al.
Diagnostics 2026, 16(2), 195; https://doi.org/10.3390/diagnostics16020195

Special Issue:

“Diagnosis, Immunopathogenesis and Control of Bacterial Infections—2nd Edition”
Guest Editor: Prof. Dr. Neil Foster
Submission Deadline: 20 December 2026

“Targeting Neutrophil Extracellular Traps in Neuroinflammation: A Therapeutic Perspective on Neurodegenerative Diseases”
by Iolanda Masalskiene Costa, Alexandre Kanashiro, Giovanna Siqueira Favi Barros, Ana Julia Monteiro, Caio Santos Bonilha, Giovane Galdino and Flavio Protasio Veras
Brain Sci. 2026, 16(8), 792; https://doi.org/10.3390/brainsci16080792

“Therapeutic Advances in Major NBIA Disorders: Current Strategies and Translational Challenges”
by Floriana Cascone, Gemma Gasparini, Valeria Tiranti and Ivano Di Meo
Neurol. Int. 2026, 18(7), 133; https://doi.org/10.3390/neurolint18070133

“Targeting PD-1/PD-L1-MAPK1 Signaling by a Novel Synergistic Combination of Rivastigmine and Epigallocatechin in Alzheimer’s Disease: An Integrated In Silico Approach”
by Bhaswati Das and Marakanam Srinivasan Umashankar
Sci. Pharm. 2026, 94(3), 57; https://doi.org/10.3390/scipharm94030057

“Epstein–Barr Virus and Multiple Sclerosis: A Narrative Review on Prevention and the Concept of an Infection-Driven Disease”
by Lou Marie Salomé Schleicher, Dorotea Zivalj, Hadid Joseph Farzad Diamee, Jan Finderle, Antea Krsek and Lara Baticic
Biomedicines 2026, 14(5), 962; https://doi.org/10.3390/biomedicines14050962

“Contextual Regulation of the Kynurenine Pathway and Its Relevance for Personalized Psychiatry”
by Stephen Murata, Gregory Oxenkrug and Angelos Halaris
J. Pers. Med. 2026, 16(2), 118; https://doi.org/10.3390/jpm16020118

“Dysregulation of Immune Mediators and Synaptic Plasticity in Central Nervous System Disorders”
by Paola Imbriani, Clara D’Ambra, Roberta De Mori, Marta Ionta, Alessandro Renna and Paola Bonsi
Cells 2026, 15(2), 201; https://doi.org/10.3390/cells15020201

“Oral Dysbiosis and Neuroinflammation: Implications for Alzheimer’s, Parkinson’s and Mood Disorders”
by Laura Carolina Zavala-Medina, Joan Sebastian Salas-Leiva, Carlos Esteban Villegas-Mercado, Juan Antonio Arreguín-Cano, Uriel Soto-Barreras, Sandra Aidé Santana-Delgado, Ana Delia Larrinua-Pacheco, María Fernanda García-Vega and Mercedes Bermúdez
Microorganisms 2026, 14(1), 143; https://doi.org/10.3390/microorganisms14010143

Special Issues:

“Inflammation at the Nexus of Neurodegeneration: Cellular Mechanisms, Biomarkers and Therapeutic Targets”
Guest Editor: Dr. Kirstan A. Vessey
Deadline for manuscript submissions: 15 December 2026
“Advances in Neuropharmacology and Brain Injury Therapeutics”
Guest Editors: Dr. Bruce X.W. Wong and Dr. Kaelyn Tan
Deadline for manuscript submissions: 25 March 2027

9 September 2026
Meet Us at Nutrients 2026—Clinical Nutrition: from Research to Practice, 22–24 October 2026, Barcelona, Spain


MDPI will attend the Nutrients 2026 Conference as the organizer and exhibitor. This event will be held in Barcelona, Spain, from 22 to 24 October 2026.

As a leading academic conference in the field of nutrition and health sciences, this event gathers renowned experts, scholars, clinicians and industry practitioners from around the world. It covers frontier research and practical applications in nutritional intervention, metabolic health, pediatric care, dairy nutrition, dietary management and antioxidant science, with multiple parallel sessions and keynote forums to promote in-depth academic exchange and industry collaboration.

The following open access journals will be represented at the conference:

If you are planning to attend the above event, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at our booth and answering any questions you may have. For more information about the conference, please visit the following website: https://sciforum.net/event/Nutrients2026.

2 September 2026
Diabetology | Invitation to Read Papers Related to Diabetic Foot


As all articles published in Diabetology (ISSN 2673-4540) are open access, the full text of every paper is fully free and accessible to all readers without restrictions. The following papers cover cutting-edge work linking diabetic foot published in 2025 and 2026. We warmly invite you to dive into these valuable studies.

1. “The Role of Vitamin C in Wound Healing in Surgically Managed Diabetic Foot Disease”
by Kiran Kancherla, Jason Chow, Rajat Mittal, Nakul Kaushik, Tamer Kamal, Gary Low and Brian Martin
Diabetology 2025, 6(2), 9; https://doi.org/10.3390/diabetology6020009

2. “Bone Substitute in Diabetic Foot Osteomyelitis Treatment”
by Roberto Da Ros, Roberta Assaloni, Andrea Michelli, Barbara Brunato, Enrica Barro and Cesare Miranda
Diabetology 2025, 6(4), 30; https://doi.org/10.3390/diabetology6040030

3. “5-Year Follow-Up of Advanced Therapy Use in High-Risk Diabetic Foot Ulcers”
by Margaret Doucette, Stephanie Seabolt, Kattie Payne and Jeremy Boyd
Diabetology 2025, 6(7), 61; https://doi.org/10.3390/diabetology6070061

4. “Machine Learning for Causal Inference in Hospital Diabetes Care: TMLE Analysis of Selection Bias in Diabetic Foot Infection Treatment—A Cautionary Tale”
by Rim Hur and Robert Rushakoff
Diabetology 2025, 6(11), 122; https://doi.org/10.3390/diabetology6110122

5. “Negative-Pressure Wound Therapy in Diabetic Foot Management: Synthesis of International Randomized Evidence over Two Decades”
by George Theodorakopoulos and David G. Armstrong
Diabetology 2025, 6(11), 126; https://doi.org/10.3390/diabetology6110126

6. “New Therapeutic Perspectives for the Management of Diabetic Foot Through Regenerative Medicine”
by Diego Castro Musial, Talita Ferreira Marques Aguiar and Guilherme H. Souza Bomfim
Diabetology 2026, 7(2), 35; https://doi.org/10.3390/diabetology7020035

7. “Outcomes of Patients Admitted for Infected Diabetic Foot Attack: Difference Between Patients with and Without Peripheral Artery Disease”
by Federico Rolando Bonanni, Marco Meloni, Martina Salvi, Ermanno Bellizzi, Luigi Uccioli, Valeria Ruotolo, Aikaterini Andreadi, Alfonso Bellia and Davide Lauro
Diabetology 2026, 7(2), 39; https://doi.org/10.3390/diabetology7020039

8. “From Plaster to Pixels: The Evolution of Offloading in the Diabetic Foot”
by David G. Armstrong, Bijan Najafi and Shervanthi Homer‑Vanniasinkam
Diabetology 2026, 7(3), 44; https://doi.org/10.3390/diabetology7030044

9. “Medicaid Insurance Is Independently Associated with Higher Risks of Diabetic Foot Infection and Amputation: A National Cohort Study”
by Carrie Tackett, Kevin Sun, Chia‑Ding Shih, Laura Shin, Elizabeth Miranda, David G. Armstrong and Tze‑Woei Tan
Diabetology 2026, 7(3), 52; https://doi.org/10.3390/diabetology7030052

10. “Preoperative Optimization in Patients with Diabetes Undergoing Foot and Ankle Surgery: BMI, Glycemic Control, and GLP-1 Agonists”
by Kaitlyn Leslie Hurka, Arun Kiran Movva, Anoop Sunkara, Siddhartha Kalala, Michael O’Connor Sohn, Kishen Mitra and Albert Thomas Anastasio
Diabetology 2026, 7(3), 54; https://doi.org/10.3390/diabetology7030054

11. “Oxygen-Enriched Oil-Based Dressing: A New Option for Tunneling Post-Surgical Diabetic Foot Ulcers”
by Alessia Scatena, Sara Sandroni, Matteo Apicella, Michele Mantuano, Anna Ranchelli, Emanuele Bartolini, Rosa Nigro, Sofia Butini, Teresa Scognamiglio, Tommaso Anichini et al.
Diabetology 2026, 7(3), 55; https://doi.org/10.3390/diabetology7030055

12. “Evaluation of the Present Perspective on Diabetic Foot Syndrome and Health Education and Analysis of the Impact of Educational Interventions: A Systematic Review and Meta-Analysis”
by Sol Tejeda‑Ramírez, José Luis Lázaro‑Martínez, Esther García‑Morales, Sara García‑Oreja, Laura Palacios‑Abril and Aroa Tardáguila‑García
Diabetology 2026, 7(4), 69; https://doi.org/10.3390/diabetology7040069

13. “Cost-Effectiveness of Pressure-Guided-Offloading-Improved Custom-Made Footwear for People with Diabetes at High Risk of Plantar Foot Ulceration”
by Sicco A. Bus, Jaap J. van Netten, Diekje R. Schouten and Marcel G. W. Dijkgraaf
Diabetology 2026, 7(4), 70; https://doi.org/10.3390/diabetology7040070

14. “Medical Doctors, Nurses, and Therapeutic Health Practitioners Knowledge of Risk Factors and Prevention of Diabetic Foot Ulcer: A Cross-Sectional Survey in a South African Setting”
by Tshifhiwa Mukheli, Anschen Fourie, Tshepo P. Mokoena, Shingirai B. Kagodora and Thifhelimbilu E. Luvhengo
Diabetology 2025, 6(4), 31; https://doi.org/10.3390/diabetology6040031

15. “Infrared Thermography in Diabetic Foot Assessment: Review”
by Thelma I. Morales‑Ramírez, Daniel Román‑Rojas and Aurora Espinoza‑Valdez
Diabetology 2026, 7(3), 47; https://doi.org/10.3390/diabetology7030047

1 September 2026
MDPI INSIGHTS: The CEO’s Letter #38 - 2 Million Published Articles, Outstanding Reviewers, Michele Parrinello Award, AIS 2026 & WSF-12

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Reaches 2 million Published Articles

This month, MDPI reached an important milestone: the publication of our two-millionth article.

It is a number that would have been difficult to imagine in 1996, when MDPI’s first journal, Molecules, published its first volume of 74 papers. It took 25 years to reach our first million published articles in December 2022, and less than four years to reach the second million in August 2026.

From 74 Papers to Two Million Articles

The milestone also comes during our 30th anniversary year, providing another opportunity to reflect on how both MDPI and Open Access publishing have developed over the past three decades. Today, more than half of the world’s published research is Open Access, while MDPI has grown into a portfolio of journals supported by more than 70,000 Editorial Board Members. In 2025 alone, articles published in MDPI journals received 1.9 billion views and downloads.

While two million is an impressive number, what matters most is what sits behind it. Every article represents research conducted and shared by authors, editorial decisions made by academic editors, expertise contributed by reviewers, and the work of colleagues across MDPI supporting the publication and dissemination of research.

Many of the stories in this month’s CEO Letter reflect these communities. We recognize the contributions of the more than 209,000 reviewers who supported MDPI journals in 2025, celebrate scientific excellence through the inaugural Michele Parrinello Award, and look at how communities continue to develop through AIS 2026 and the 12th World Sustainability Forum.

“In 2025 alone, articles published in MDPI journals received 1.9 billion views and downloads”

Publishing at Scale, with Purpose

Reaching two million articles is an important milestone in MDPI’s history, but it is also a reminder of the responsibility that comes with publishing at this scale. As we look ahead, our focus remains on quality, research integrity, strong editorial standards, and providing researchers with reliable and efficient ways to share their work openly with the world.

Thank you to our authors, editors, reviewers, institutional partners, and colleagues around the world who have contributed to this journey.

Impactful Research

Recognizing Scientific Excellence: The Michele Parrinello Award

Supporting researchers means more than publishing and disseminating scientific work. It also means recognizing the researchers, editors, reviewers, and scholars whose contributions advance their fields.

I’m pleased to highlight the inaugural Michele Parrinello Award, which has been awarded to Prof. Ursula Röthlisberger of the École Polytechnique Fédérale de Lausanne (EPFL), Switzerland. Prof. Röthlisberger was recognized for her contributions to computational chemistry and molecular simulation, particularly her pioneering work in ab initio molecular dynamics and quantum mechanical/molecular mechanical (QM/MM) multiscale simulation methods. 

Prof. Röthlisberger leads the Laboratory of Computational Chemistry and Biochemistry at EPFL, developing computational approaches to understand complex chemical, biological, and materials systems at the atomic level. Her work also extends to next-generation photovoltaic materials, demonstrating the interdisciplinary reach of computational science.

The Michele Parrinello Award was established in 2025 to honor Prof. Michele Parrinello's pioneering contributions to atomistic simulation and computational science. Presented biennially, it recognizes senior researchers who have made significant contributions across physics, chemistry, and materials science. The recipient receives a EUR 50,000 prize, commemorative medal, and certificate.

Awarding Scientific Excellence

The selection was overseen by an international Award Committee, chaired by Prof. Dr. Xin-Gao Gong of Fudan University and a group of researchers from institutions in China, Italy, the UK, and the USA. Nominations were evaluated based on rigor, integrity, and academic excellence. In announcing the winner, Prof. Gong highlighted the impact of Prof. Röthlisberger’s research across multiple scientific disciplines, alongside her contributions to education and leadership within the international research community.

Recognizing Contributions Across the Research Community

The Michele Parrinello Award is part of MDPI’s broader commitment to recognizing excellence across different disciplines, contributions, and career stages.

Our journal awards include:

  • Best Paper Awards – recognizing outstanding published research
  • Young Investigator Awards – supporting exceptional early-career researchers
  • Best PhD Thesis Awards – recognizing promising emerging scholars
  • Outstanding Reviewer Awards – acknowledging the essential contribution of peer reviewers
  • Travel Awards – helping early-career researchers participate in international conferences
  • Editor of Distinction Awards – recognizing exceptional contributions from Editorial Board Members.

Alongside these journal awards, MDPI supports flagship initiatives including the Tu Youyou Award, the World Sustainability Award, the Emerging Sustainability Leader Award, and now the Michele Parrinello Award.

Learn More: 

Inside MDPI

Recognizing the People Behind Peer Review: MDPI’s 2025 Outstanding Reviewer Awards

Behind every published article is a network of people contributing their expertise to the scholarly record. Among them, reviewers play an essential role, providing independent assessment, feedback, and subject expertise that help editors make informed decisions and authors build on their research.

In 2025, more than 209,000 individuals contributed their expertise as reviewers for MDPI journals. This represents an enormous contribution of time and knowledge from researchers around the world, occurring often alongside their own research, teaching, and professional responsibilities.

I’m pleased to share the recipients of MDPI’s 2025 Outstanding Reviewer Awards, recognizing reviewers who have shown great dedication, expertise, and responsiveness throughout the peer-review process.

Outstanding Reviewers

As at July 2026, 181 MDPI journals have presented Outstanding Reviewer Awards to 412 recipients, highlighting their work across disciplines ranging from biology, chemistry, engineering, and medicine to environmental sciences, public health, and the social sciences. To learn more about the list of outstanding reviewers, please visit the following pages:

While these awards highlight a select group of outstanding contributors, they also create an opportunity to acknowledge our entire reviewer community. Peer review depends on researchers sharing their knowledge and experience with others. Their feedback can improve manuscripts, support editors in making informed decisions, and contribute to maintaining the quality and integrity of the scientific record.

“Reviewers play an essential role, providing independent assessment, feedback, and subject expertise”

Supporting the Academic Community

The Outstanding Reviewer Awards are part of MDPI’s awards program, through which our journals recognize contributions across the academic community, including those from researchers, early-career scholars, reviewers, and Editorial Board Members.

Bringing these contributions to the forefront is important because much of the work that supports scholarly publishing happens behind the scenes. The time, expertise, and critical feedback provided by reviewers are essential to a rigorous and constructive peer-review process.

As MDPI celebrates its 30th anniversary, I would like to thank the more than 209,000 reviewers who contributed to our journals in 2025 and to congratulate the 412 Outstanding Reviewer Award recipients recognized for going above and beyond in supporting their respective research communities.

Coming Together for Science 

AIS 2026: Growing a Community Around AI and Sensor Research

One of the most rewarding aspects of our conference program is seeing scientific communities develop over time. A conference may begin by bringing together researchers around an emerging field, but with each edition it can create new relationships, collaborations, and opportunities for researchers to reconnect and exchange ideas.

The 3rd International Conference on AI Sensors and Transducers (AIS 2026) is a good example of this growth.

“What stands out is the community developing around AIS”

This year’s conference took place from 2 to 7 August in Jeju, South Korea, welcoming over 560 participants – an increase of 225 attendees compared with 2025 and 160 compared with the inaugural conference of 2024. Across the program, participants contributed 373 presentations and 109 poster displays, including four plenary presentations, 52 keynote speeches, 192 invited talks, and 125 oral presentations.

Building an International Research Community

Beyond the numbers, what stands out is the community developing around AIS. Many researchers have now participated in all three editions of the conference, with delegates already expressing their intention to return for AIS 2027. The program also brought together established researchers from across the field for discussions on AI sensors and emerging sensing technologies.

Building Engagement in South Korea

This year’s conference reflects our continued engagement with the research community in South Korea. AIS 2026 welcomed 150 participants from the Korean academic community and strengthened our cooperation with the Korean Sensors Society.

This is an important part of what our conferences can achieve. By bringing researchers together in person, we create opportunities to present the latest research and build relationships between scholars, institutions, societies, and at MDPI that can continue after an event concludes.

Looking Ahead

With this momentum, AIS 2027 is planned for 29 July to 3 August 2027 in Kunming, Yunnan, China, with the participation of an international group of Conference Chairs already confirmed from institutions in Europe, North America, and Asia-Pacific.

Three editions into AIS, the continued growth of this conference shows what is possible when we invest consistently in scientific communities. The objective is not simply to organize larger conferences each year but to create spaces where researchers return, new collaborations develop, and scientific communities become stronger.

Many thanks to the Conference Chairs, speakers, sponsors, supporting organizations, participants, and all MDPI colleagues who contributed to AIS 2026. Growing an international event takes years of relationship-building and considerable work behind the scenes, and this year’s conference reflects that collective effort.

Closing Thoughts

World Sustainability Forum 12: Coming Together for a More Sustainable Future

Sustainability challenges rarely sit within a single discipline, institution, or country. Addressing them requires researchers, policymakers, industry, and communities to exchange ideas and work across traditional boundaries.

This is one of the ideas behind the World Sustainability Forum (WSF), which has now reached its 12th edition.

From 21 to 24 August, the 12th World Sustainability Forum (WSF-12) took place in Hong Kong, bringing together more than 300 experts, scholars, policymakers, and industry representatives from over 100 universities and research institutions across 53 countries and regions. The Forum received 543 abstract submissions, showcasing international interest in sustainability research.

Connecting Research, Policy, and Industry

Across four days, the scientific program featured 230 onsite presentations, including plenary, keynote, invited and oral presentations, together with 53 poster presentations. The program also included a plenary panel discussion, Connecting Sustainability Solutions Across Sectors, presenting perspectives from academia, government, and industry.

This interdisciplinary exchange is particularly important in sustainability research. Challenges relating to our cities, environment, energy systems, economies, and societies are increasingly interconnected, and progress depends on creating opportunities for different disciplines and sectors to learn from one another.

WSF-12 also generated opportunities for industry participation. As a Strategic Partner, the China National Petroleum Corporation (CNPC) E-Light International Communication Brand contributed to industry engagement throughout the Forum.

MDPI Sustainability Foundation Awards

Another highlight of WSF-12 was the presentation of three MDPI Sustainability Foundation Awards, celebrating the 2025 and 2026 winners of the World Sustainability Award and the 2026 winner of the Emerging Sustainability Leader Award.

Recognizing researchers and emerging leaders in their fields is an important part of supporting scientific communities. These awards are an opportunity to celebrate individual achievements and highlight research that contributes to a more sustainable future.

Looking Ahead to WSF-13

After twelve editions, WSF is a great example of how a scientific community can develop over time. This is also what we hope to achieve through MDPI’s broader conference program. Scientific meetings should be more than individual events: by investing consistently in research communities, we can create spaces where people return, new relationships develop, different perspectives meet, and collaboration continues beyond the conference itself.

The next chapter is already taking shape. The 13th World Sustainability Forum(WSF-13) will take place from 8 to 11 June 2027 in Nice, France. Chaired by Prof. Dr. Adel Ben Youssef and organized by MDPI and the journal Sustainability in collaboration with Université Côte d’Azur, WSF-13 will continue the Forum’s interdisciplinary approach across the natural sciences, engineering, and social sciences.

Thank You

Many thanks to the Conference Chairs, speakers, strategic partners, sponsors, supporting organizations, participants, and all MDPI colleagues who contributed to WSF-12. Events of this scale require considerable coordination and collaboration behind the scenes, and the continued growth of WSF reflects the collective efforts of the MDPI Conference Department and a global community committed to sustainability research, innovation, and collaboration.

Stefan Tochev
Chief Executive Officer
MDPI AG

6 August 2026
Meet Us at the 22nd EuGMS Congress, 16–18 September 2026, Lille, France


Conference: 22nd EuGMS Congress
Date: 16–18 September 2026
Location: Lille Grand Palais, Lille, France

MDPI will be attending the 22nd EuGMS Congress, which will be held from 16 to 18 September 2026 in Lille, France.

After the resounding success of the 2025 congress in Reykjavik, which brought together over 2,000 participants, the 2026 congress will continue to advance the field of geriatric medicine, deepen collaborations, and celebrate the shared commitment to improving the care of older adults.

The theme for the 2026 congress, “Optimizing Function: a Key to Healthy Ageing”, underscores the vital role of functional capacity in ensuring quality of life and independence as we age. In a rapidly evolving healthcare landscape, this focus is more important than ever.

The following open access journals will be represented at the conference:

If you are planning to attend the above conference, please do not hesitate to visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit the following website:
https://eugms2026.com/.

Of the participating journals, Geriatrics is celebrating its 10th anniversary:

2026 marks the 10th anniversary of Geriatrics (ISSN 2308-3417), a peer-reviewed open access journal on geriatric medicine published by MDPI. With an Impact Factor of 2.4 and a CiteScore of 3.4, the journal is covered in Scopus, ESCI (Web of Science), PubMed, PMC, and other databases. The journal has published more than 1000 papers by more than 4000 authors. More than 2000 reviewers have reviewed submissions to the journal at least once. We equally value the contributions made by our editors, authors, and reviewers.

Geriatrics invites you to celebrate this milestone and explore the 10th anniversary website: https://www.mdpi.com/journal/geriatrics/anniversary.

5 August 2026
MDPI INSIGHTS: The CEO’s Letter #37 - Canada Summit, Sciforum Relaunch, 30 Years of Impactful Research & ISPRS 2026

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Reflections from the MDPI Canada Summit 2026 in Toronto (9–10 July)

As part of this year’s MDPI Summit events, we were delighted to host Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) in Toronto for the MDPI Canada Summit 2026 this July.

Across the two days, we presented on topics including research integrity, editorial leadership, artificial intelligence, peer review, and the evolving role of the EiC. More importantly, the Summit created space for feedback and conversations with the academic community: these engagements continue play and important role in shaping how MDPI develops its journals and services.

Why Canada?

Canada has become one of the world’s leading Open Access (OA) nations. In 2025, 68% of Canadian research publications were published OA, with more than 73,000 OA articles produced during the year. Over the past five years alone, Canadian researchers have published more than 526,000 scholarly articles, showing both the scale and quality of Canadian research.

MDPI Toronto Office

“Canada has become one of the world’s leading Open Access nations”

Since opening in 2019, our Toronto office has grown to more than 85 colleagues supporting editorial operations, research integrity, marketing, societies, conferences, indexing, author services, and many other functions across North America. It was great to spend time with the team, see first-hand the energy and enthusiasm they bring to their work, and recognize the significant role they play in building relationships with the Canadian research community and delivering events such as this Summit.

MDPI and Canada

Today, Canada is an important part of the MDPI community:

  • More than 53,800 articles from Canadian institutions published with MDPI since 1996
  • More than 5,800 MDPI publications from Canadian researchers in 2025
  • Nearly 1,900 Canadian Editorial Board Members, including 24 Editors-in-Chief; 49 Section Editors-in-Chief
  • More than 30 Institutional Open Access Partnerships (IOAP) with universities across Canada

“The academic community is at the center of everything we do”

These numbers reflect the long-term partnerships with researchers, reviewers, editors, and institutions who continue to place their trust in MDPI.

Summit Program

Throughout the Summit, we presented and discussed topics against the following agenda:

  • MDPI at 30: Introduction, Reflections and the Road Ahead – Stefan Tochev (CEO)
  • Engagement with Academic Community and Society Partnerships – Karen Irwin (Associate Editorial Engagement Manager) and Carla Aloè (Head of Societies and Acquisition)
  • Latest Developments in the Editorial Process – Summer Huggard (Operations Manager)
  • Research Integrity and Publication Ethics – Renato Merki (Research Integrity Specialist)
  • AI and Technology in Publishing – Dr. Barnaby Crook (Regional Engagement Editor)
  • Panel Discussion – Bob Vrooman (Head of Business Development / Operations Manager, USA), Summer Huggard, Renato Merki, and myself

These presentations reinforce something we often say at MDPI: The academic community is at the center of everything we do. Each session concluded with a Q&A, allowing for discussions throughout the Summit to engage directly with our EiCs and EBMs.

Further Reading

I also had the opportunity to be interviewed by University Affairs about the evolving landscape of scholarly publishing, Open Access, and the importance of engaging with the research community. If you’re interested, you can read the interview in:

Thank You

As OA continues to grow around the world, events such as the MDPI Canada Summit remind us of the importance of meeting with our academic community in person. Listening to feedback, exchanging ideas, and building relationships are essential to ensuring that MDPI continues to evolve alongside the researchers, editors, reviewers, and institutions we serve.

Impactful Research

Five Journals, Five Different Stories of Success

Each year, the release of the Journal Citation Reports (JCR) provides an opportunity to look at the progress of our journal portfolio and, more importantly, the achievements of the research communities behind it.

A recent MDPI Blog article from Tommy Lax (Content Specialist, MDPI) highlights five journals whose 2025 Journal Impact Factor results show that success can take many forms –  from achieving a first Impact Factor, to steady long-term growth, to leadership within highly competitive disciplines.

The featured journals include:

  • Machine Learning & Knowledge Extraction (MAKE) – Among the 330 MDPI journals which received an Impact Factor in 2025, MAKE (ISSN 2504-4990) holds the accolade of having the highest rating of 8.4. The journal, which provides an advanced forum for the study of machine learning and its applications, is placed in Q1 for three subject categories: Computer science, artificial intelligence; Computer science, interdisciplinary applications; and Engineering, electrical & electronic.
  • Antioxidants – Continuing its strong position across multiple scientific disciplines, Antioxidants (ISSN 2076-3921) was awarded an exceptional Impact Factor of 8.2. In addition, the journal was placed in Q1 in three subject categories: Biochemistry & molecular biology; Chemistry, medicinal; and Food science & technology.
  • Biomass – This year, Biomass (ISSN 2673-8783) was recognized in the JCR for the first time, with a strong debut Impact Factor of 6.7. What makes this achievement even more impressive is the journal’s placement in Q1 of the category Engineering, chemical.
  • Analytica – Remaining with the theme of growth, Analytica (ISSN 2673-4532), which provides an advanced forum for all aspects of fundamental and applied analytical chemistry, recorded one of the largest year-on-year increases in Journal Impact Factor, with a 7.4 – an astounding 3.8-point increase from its 2024 rating of 3.6.
  • Batteries – Indexed in SCIE, Batteries (ISSN 2313-0105) received an updated Impact Factor of 6.3 this year, representing an increase of 1.5 versus last year, demonstrating consistent growth and increasing visibility over several years.

While citation metrics provide one perspective on journal performance, they tell only part of the story. Every milestone reflects the dedication of Editors-in-Chief, Editorial Board Members, reviewers, authors, and colleagues across MDPI who work together to uphold rigorous editorial standards and support high-quality research.

As a signatory of the Declaration on Research Assessment (DORA), MDPI supports a balanced approach to research evaluation. Journal-level metrics should be viewed alongside article-level indicators and the broader scientific and societal impact of published research.

Thank you to everyone whose commitment continues to strengthen our journals and advance Open Access across the global research community.

Inside MDPI

Building Better Tools for the Research Community: The Relaunch of Sciforum

Innovation at MDPI extends beyond journals. Over the past decade, we have continued to invest in products that support researchers, conference organizers, editors, reviewers, and institutions throughout the research lifecycle. As part of this ongoing investment, our Product and Engineering teams have been modernizing several of MDPI’s digital platforms. One important milestone in that journey is the relaunch of Sciforum, our conference management platform.

Read More: Sciforum Relaunch: Empowering Science through Seamless Event Management

Rather than simply updating an existing system, our product and engineering teams have rebuilt Sciforum, using a modern architecture designed to improve the user experience, support future growth, and continue to strengthen our position in the conference management market.

“Scalable technology is essential to delivering a high-quality experience”

Why We Rebuilt Sciforum

Technology must continue evolving alongside the needs of our users. The previous platform had served MDPI well for many years but had become difficult to extend and maintain. The new platform introduces a modular architecture that enables faster development, more flexibility, and a scalable foundation for future work.

Major improvements include:

  • Simplified submission workflows
  • Role-based dashboards
  • A modern website builder
  • Flexible pricing options
  • Permanent data hosting
  • A scalable architecture for future development

 

Supporting Our Conference Community

Sciforum is more than a software platform: it supports researchers, conference organizers, reviewers, speakers, and attendees by helping them organize, participate in, and share scientific meetings more efficiently. As MDPI continues to expand its conference activities worldwide, investing in modern, scalable technology is essential to delivering a high-quality experience for both our external partners and our internal teams.

Looking Ahead

The relaunch represents the beginning Sciforum’s next chapter. Planned improvements include: the Program Builder, Communication Hub, expanded payment options, Zoom integration, and a mobile application. These will continue to enhance the platform over the coming months.

Coming Together for Science

Highlights from ISPRS Congress 2026 – Toronto, Canada

In early July, I had the pleasure of attending the XXV ISPRS Congress in Toronto, one of the world’s leading gatherings for the geospatial and remote sensing research community. It was a great opportunity to meet researchers, editors, society leaders, and collaborators, while gaining insights into some of the latest developments in geospatial science and technology. 

Over several days, I had the privilege of presenting the Jack Dangermond Award; speaking about MDPI’s approach to AI in publishing and our 30-year journey in Open Access publishing; participating in Editorial Board meetings; and engaging with members of the ISPRS community. 

Below is a summary of these activities:

Celebrating excellence in research

One of the highlights of the week was presenting the Jack Dangermond Award for the best paper published in the ISPRS International Journal of Geo-Information (IJGI). Sponsored by MDPI and ESRI, the award recognizes an outstanding paper published over a four-year period and includes an ISPRS certificate together with a USD 10,000 prize.

Awards such as these remind us that journals are much more than publication platforms: they celebrate research that advances knowledge, inspires future work, and delivers meaningful impact for both science and society.

Presentations at ISPRS

I also had the pleasure to give two presentations during the congress:

1. The AI Revolution in Publishing: Challenges, Innovations, and MDPI’s Vision

The development of AI continues to transform scholarly publishing. During this session, I shared how MDPI is integrating AI responsibly, not to replace editorial judgement or peer review, but to support our staff by improving efficiency while maintaining scientific quality and research integrity.

2. MDPI: 30 Years of Open Access Publishing

I also had the opportunity to share MDP’s 30-year journey from a small publishing initiative to becoming a global Open Access publisher serving millions of researchers worldwide. As part of this session, my colleague Carla Aloè (Head of Societies and Acquisitions) introduced the ISPRS International Journal of Geo-Information (IJGI), sharing its development and contribution to the geospatial research community.

Meeting with Our Editorial Boards

Another rewarding aspect of the congress was meeting with the Editorial Boards of two of our journals:

  • Remote Sensing
  • ISPRS International Journal of Geo-Information

These discussions went beyond journal metrics. We heard ideas about editorial quality and emerging research areas, and we discussed reviewer engagement, diversity within editorial boards, and how journals can continue serving their communities for the future. These conversations are a great way to connect directly to the scientists who help shape our journals.

“One of our core missions has always been to make high-quality research openly accessible”

Partnerships matter

Scientific publishing is built on collaboration. Throughout the congress, our team welcomed researchers to the MDPI booth, met with authors and editors, and discussed opportunities for collaboration across our journals and society partnerships.

Special thanks to our MDPI colleagues who were present throughout the ISPRS congress supporting our Editorial Board meetings and the MDPI booth: Andy Tran, Carla Aloè, Carlo Cunanan, Diana Ribeiro Tosato, and Elena Duan.

Thank you to ISPRS for organizing this congress, to the researchers who shared their work, to our Editorial Board members, and to MDPI colleagues whose dedication continues to shape the journals and communities we support.

Closing Thoughts

Insights Into 30 Years of Impactful MDPI Research

As we celebrate 30 years of MDPI, it’s worth reflecting on the impact that the research we publish has on society. One of our core missions has always been to make high-quality research openly accessible so that it can inform new discoveries, public policy, education and innovation around the world.

A recent article on the MDPI Blog highlights several examples of MDPI publications that have gone beyond academic citations to help inform governments, international organizations and public policy discussions.

Research Creating Real-World Impact

The MDPI blog article features research that has contributed to topics including:

  • protecting the Amazon rainforest through satellite mapping
  • understanding climate change and urban heat inequality
  • encouraging more young women to pursue STEM careers
  • tackling obesity through healthier food environments
  • shaping sustainable urban planning through the “15-minute city” concept

These examples remind us that publishing research is not only about producing articles: it is about helping knowledge reach the people who can use it to improve lives and address global challenges.

Thirty Years of Open Access

MDPI’s 30th Anniversary is also an opportunity to recognize the collective contribution of everyone across MDPI. Every manuscript processed, every review coordinated, every system developed, every conference organized, every partnership established and every article published contributes to a much larger purpose: helping scientific knowledge move further and faster.

You can explore the full article here: 30 Years of Impactful MDPI Research

You can also visit our 30th Anniversary page to learn more about MDPI’s journey over the past three decades.

Stefan Tochev
Chief Executive Officer
MDPI AG

4 August 2026
Meet Us at the 38th European Congress of Pathology (ECP 2026), 12–16 September 2026, Stockholm, Sweden


Conference: 38th European Congress of Pathology (ECP 2026)
Date: 12–16 September 2025
Location: Stockholm, Sweden

ECP 2026 will bring together more than 5000 participants from all over the world—pathologists, clinicians, researchers, molecular biologists, bioinformaticians, medical scientists, and industry partners. The meeting will provide an ideal opportunity for professional development, networking, and exchanging insights, and will demonstrate the commitment of the ESP to contributing to pathology progress in the near future. You can view the detailed conference topics here: https://www.espcongress.org/topics/.

We will be attending the 38th European Congress of Pathology (ECP 2026), and we welcome researchers from different backgrounds to visit and share their latest ideas with us.

The following open access journals will be represented:

If you plan to attend this conference, please contact us online. Our delegates look forward to meeting you in person at booth #121 (Hall B) and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.espcongress.org/welcome-address/.

Back to TopTop